FOUNDED IN 1996

OUR RESEARCHPUBLICATIONS

UNIQUE EXPERTISE

Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.

UNIQUE CAPABILITIES

We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.

UNRIVALED CAPABILITIES

OUR PUBLICATIONS

We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.

SELECTED PUBLICATIONS

NEWS

DeCODE genetics publishes the largest ever study of the plasma proteome

DeCODE genetics publishes the largest ever study of the plasma proteome

In a study published in Nature genetics, scientists at deCODE genetics demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with data on sequence diversity and RNA expression dramatically increases insights into human diseases and other phenotypes.

New study on inheritance and fetal growth

New study on inheritance and fetal growth

Scientists from deCODE genetics have mapped 243 sequence variants affecting fetal growth, separating maternal genome and fetal genome. It sheds light on the relationships between hypertension, diabetes and fetal growth

Award by the American Society of Human Genetics

At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.